NCT01329237

Brief Summary

The purpose of the study is to compare strut coverage and neointimal thickness between everolimus eluting (XIENCE-V® or PROMUS® stent) and biolimus A9 eluting NOBORI Stent 14 months after stent implantation and to determine the coronary endothelial function after everolimus eluting (XIENCE-V® or PROMUS® stent) and biolimus A9 eluting NOBORI Stent 14 months after stent implantation by using supine bicycle exercise testing to assess coronary vasomotor response to exercise.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at below P25 for phase_4 coronary-artery-disease

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2011

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

March 28, 2011

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 5, 2011

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2012

Completed
Last Updated

April 5, 2011

Status Verified

January 1, 2011

Enrollment Period

1 year

First QC Date

March 28, 2011

Last Update Submit

April 4, 2011

Conditions

Keywords

drug-eluting stentcoronary endothelial functioncoronary imaging

Outcome Measures

Primary Outcomes (1)

  • percentage of uncovered stent struts per lesion assessed by OCT

    within 14 months after percutaneous coronary stent implantation

Secondary Outcomes (2)

  • coronary vasomotor function

    within 14 months after stentimplantation

  • mean neointimal thickness assessed by OCT

    within 14 months after stent implantation

Study Arms (1)

dynamic physical exercise OCT

OTHER

dynamic physical exercise and optical coherence tomography imaging

Other: dynamic physical exercise and OCT imaging

Interventions

supine dynamic physical exercise during coronary angiography and optical coherence tomography OCT imaging of the coronary stent

dynamic physical exercise OCT

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient enrolled in the COMPARE II trial with successful stent implantation and absence of binary restenosis or severe progression of coronary artery disease at 14 months follow-up.
  • Patient consent to undergo a non-scheduled follow- up angiography with imaging study and bicycle exercise testing

You may not qualify if:

  • Inability to provide informed consent
  • Inability to perform a supine bicycle exercise stress test
  • Binary in stent restenosis of the target vessel
  • Acute Coronary Syndrome, Acute Myocardial Infarction
  • Patients with stent thrombosis following the index procedure
  • Female of childbearing potential ( age ≤ 50 years and last menstruation within the last 12 months ), who did not undergo tubal ligation, ovariectomy or hysterectomy
  • Known intolerance to heparin, contrast material
  • History of bleeding diathesis or known coagulopathy
  • Age ≥ 80 years
  • Hemodynamic instability
  • Renal failure (creatinine clearance ≤ 40 ml/min)
  • OCT / IVUS technically not feasible

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hopital Cantonal HFR

Fribourg, Canton of Fribourg, 1708, Switzerland

RECRUITING

MeSH Terms

Conditions

Coronary Artery Disease

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Study Officials

  • Mario Togni, MD

    University of Fribourg, Switzerland

    PRINCIPAL INVESTIGATOR
  • Stéphane Cook, MD

    University of Fribourg, Switzerland

    PRINCIPAL INVESTIGATOR
  • Jean-Christophe Stauffer, MD

    Hopital Cantonal HFR, Fribourg, Switzerland

    STUDY CHAIR
  • Jean-Jacques Goy, MD

    Hopital Cantonal HFR, Fribourg, Switzerland

    STUDY CHAIR
  • Gérard Baeriswyl, MD

    Hopital Cantonal HFR, Fribourg, Switzerland

    STUDY CHAIR
  • Pieter C Smits, MD, PhD

    Maasstad Ziekenhuis, Rotterdam, The Netherlands

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
phase 4
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER

Study Record Dates

First Submitted

March 28, 2011

First Posted

April 5, 2011

Study Start

March 1, 2011

Primary Completion

March 1, 2012

Last Updated

April 5, 2011

Record last verified: 2011-01

Locations